| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |